Bioabsorbable Stents Market Size, Scope And Growth 2025 To 2034


Unlock 20% Off Global Market Reports Using Code ONLINE20 – Stay Informed on Trade Policies, Market Growth, and Key Disruptors

What Is the Forecast Market Size and Growth Rate of the Bioabsorbable Stents Market by Region?
The bioabsorbable stents market size has grown strongly in recent years. It will grow from $0.37 billion in 2024 to $0.41 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, growing demand for minimally invasive procedures, increasing awareness of bioabsorbable stents, rising disposable incomes, industry investments.

The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to expanded clinical indications, customization and personalization, global expansion, patient-friendly option. Major trends in the forecast period include advancements in bioabsorbable materials, clinical advancements, clinical data and research, hybrid stent designs, longer absorption periods, collaborations and partnerships.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

What Are the Top Drivers and Growth Contributors in the Bioabsorbable Stents Market?
The increasing rate of heart failure is expected to drive the growth of bioabsorbable stents market. Heart failure is characterized by the heart muscle's reduced ability to efficiently pump blood, resulting in the accumulation of excess fluid within the body. Bioabsorbable stents can be employed in the management of heart failure to enhance cardiac performance and mitigate its symptoms. For instance, in February 2022, the Heart and Stroke Foundation of Canada, a Canada-based source of information about stroke, heart disease, surgeries and treatments, reports a current count of 750,000 individuals diagnosed with heart failure, with an annual increase of 100,000 new cases of this incurable condition. Projections indicate that by 2030, healthcare expenditures related to heart failure in Canada are anticipated to reach $2.8 billion annually. Therefore, the increasing rate of heart failure will be propelling the growth of bioabsorbable stents market going forward.

What Are the Major Product/Service Segments in the Bioabsorbable Stents Market?
The bioabsorbable stentsmarket covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents
2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents
3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:
1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents
2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

What Are the Major Trends Impacting the Bioabsorbable Stents Market?
Major companies operating in the bioabsorbable stents market are focusing on innovating new technologies, such as the Latest Generation of Bioresorbable Cardiac Stent, to increase their profitability in the market. The latest generation of bioresorbable cardiac stents refers to advanced medical devices designed for use in coronary artery disease treatment, which are made from biodegradable materials that dissolve over time after performing their function of keeping the artery open. For instance, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, recently received market approval for the world's first next-generation fully bioresorbable cardiac stent from China's National Medical Products Administration (NMPA). Developed by MicroPort Scientific Corporation, Firesorb is designed to completely dissolve within three years, significantly reducing long-term complications such as thrombosis. Clinical trials involving 1,468 patients have shown impressive results, including a low thrombosis rate of 0.32% and a 4-year target lesion failure rate of just 4.3%. Leading medical experts have praised its innovative thin strut design and superior endothelial coverage compared to previous stent generations.

Who Are the Industry Leaders in the Bioabsorbable Stents Market?
Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation

Get the full bioabsorbable stents market report here:
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Which Region Is Expected to Lead the Bioabsorbable Stents Market by 2029?
North America was the largest region in the bioabsorbable stents market in 2024. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more